Evidence map›Paper›PMID 37202807›Full record

ArticleMalaria journal2023

Cost of inappropriate prescriptions for uncomplicated malaria in Ghana.

Genevieve Cecilia Aryeetey, Justice Nonvignon, Keziah Malm, Richmond Owusu, Bright Sasu Baabu, Nana Yaw Peprah, Samuel Agyei Agyemang, Jacob Novignon, Samuel Amon, Duah Dwomoh and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Genevieve Cecilia AryeeteyDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Justice NonvignonDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana. jnonvignon@ug.edu.gh.
Keziah MalmNational Malaria Elimination Programme, Ghana Health Service, Accra, Ghana.
Richmond OwusuDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Bright Sasu BaabuDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Nana Yaw PeprahNational Malaria Elimination Programme, Ghana Health Service, Accra, Ghana.
Samuel Agyei AgyemangDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Jacob NovignonDepartment of Economics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Samuel AmonDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Duah DwomohDepartment of Biostatistics, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Moses AikinsDepartment of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
University of Ghana · GHGhana Health Service · GHKwame Nkrumah University of Science and Technology · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria remains a common course of morbidity in many sub-Saharan African countries. While treatment options have improved in recent times, inappropriate prescription seems conventional among providers, increasing the burden on patients and society. This study examined the cost of inappropriate prescriptions for uncomplicated malaria treatment in Ghana.

methodsThis study used retrospective data collected from January to December 2016 in 27 selected facilities, under different ownership in three regions of the country, mainly Volta, Upper East and Brong Ahafo. Stratified random sampling technique was used to extract 1625 outpatient folders of patients diagnosed and treated for malaria. Two physicians independently reviewed patient folders according to the stated diagnoses. Malaria prescriptions were described as inappropriate when they do not adhere to the standard treatment guidelines. The economic cost was mainly treatment cost which was sourced as medication cost. Total and average costs for country were calculated using sample estimates and the total number of uncomplicated malaria cases that received inappropriate prescriptions.

resultsThe study revealed that patients received an average of two prescriptions per malaria episode. Artemether-lumefantrine (AL) was the major malaria medication (79.5%) prescribed to patients. Other medications usually antibiotics and vitamins and minerals were included in the prescription. More than 50% of prescribers did not follow the guidelines for prescribing medications to clients. By facility type, inappropriate prescription was high in the CHPS compounds (59.1%) and by ownership, government (58.3%), private (57.5%) and mission facilities (50.7%). Thus, about 55% of malaria prescriptions were evaluated as inappropriate during the review period, which translates into economic cost of approximately US$4.52 million for the entire country in 2016. The total cost of inappropriate prescription within the study sample was estimated at US$1,088.42 while the average cost was US$1.20.

conclusionInappropriate prescription for malaria is a major threat to malaria management in Ghana. It presents a huge economic burden to the health system. Training and strict enforcement of prescribers' adherence to the standard treatment guideline is highly recommended.

Indexed as

AntimalarialsMalariaArtemetherArtemether, Lumefantrine Drug CombinationGhanaHumansInappropriate PrescribingRetrospective StudiesAntimalarialsArtemetherArtemether, Lumefantrine Drug CombinationCostGhanaInappropriateMalariaPrescription

Identifiers

PMID37202807
PMCPMC10193808
OpenAlexW4377092784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.